Top Stories
-
Amyloid sparks an alliance between two proteins in the brain that can potentially explain up to half of the gene changes that occur in Alzheimer’s.
Topic
-
Multiple sclerosis (MS) usually begins between the ages of 20 and 40 and is the most common disabling neurological disorder of young adults.
Topic
-
Columbia researchers have discovered how a genetic defect leads to spinal muscular atrophy, a finding that could lead to a new therapy for a disease that affects 1 in 6,000 children.
-
Columbia’s researchers have opened a trial of a noninvasive, focused ultrasound approach to open the blood-brain barrier, enabling higher concentrations of an effective drug to enter the brain.
Topic
Latest News
- June 27, 2013
Ottavio Arancio, MD, PhD, of CUMC's Taub Institute, coauthored a paper on a compound that prevents memory loss in a mouse model of Alzheimer's. See Northwestern's news release: http://bit.ly/14Zqwwn
Topic
- June 25, 2013
Mouse study suggests inhibiting protein called caspase-2 might prevent cognitive decline in Alzheimer's
Topic
- June 19, 2013
One in 4 stroke survivors suffer from PTSD symptoms within the 1st year post-event, and 1 in 9 experience chronic PTSD more than a year later - results of a study led by Columbia University Medical Center researchers.
Topic
- May 6, 2013
Columbia University study looks at the relationship between families with exceptional longevity and cognitive impairment consistent with Alzheimer's disease.
Topic
- May 1, 2013
Four research centers including the Center for Stroke Disparities Solutions—a partnership of the New York University Langone Medical Center and Columbia University Medical Center —will develop high-impact culturally tailored interventions aimed at lowering stroke risk among racial and ethnic minorities in the United States.
Topic
- April 17, 2013
Excess glutamate in the brain may spur psychosis in those at risk for schizophrenia, report CUMC investigators in a study published in Neuron.
Topic
-
Source:
Alzheimer Research ForumApril 10, 2013African-Americans carrying a variant in a cholesterol-processing gene, ABCA7, have double the risk for Alzheimer’s than non-carriers. A new study led by CUMC's Richard Mayeux; first author Christiane Reitz.
Topic
- April 10, 2013
Four young physician-researchers at P&S have received research funding from the Louis V. Gerstner Jr. Scholar Program.
Topic
-
Source:
The New York TimesApril 9, 2013African-Americans with Alzheimer’s disease were slightly more likely to have one gene, ABCA7, that is thought to confer risk for the disease. CUMC's Dr. Richard Mayeux led the study.
Topic
- April 9, 2013
The largest genome-wide search for Alzheimer’s genes in African-Americans has found that African-Americans with a variant of the ABCA7 gene have almost double the risk of developing late-onset Alzheimer’s disease.
Topic
